Linus Health

Linus Health offers a plug-and-play solution for the early detection, treatment, and prevention of cognitive health issues using its “DCTclock” FDA-registered technology. The solution is a spin-off from Lahey Hospital & Medical Center and MIT as a medical device for cognitive assessments deployed using built-in sensors and AI-based analysis. The technology allows care professionals to monitor seniors’ brain health remotely outside clinical settings.

In July 2021, the company stated that its technology was proven effective in detecting early signs of Alzheimer’s disease in research conducted by Massachusetts General Hospital. A more in-depth study is to be carried out by the Global Alzheimer’s Platform Foundation.

In March 2024, the company launched its new Digital Trail Making Test Part B, an FDA Class II- listed medical device, and introduced a Hearing Screener system to its AI-based digital cognitive assessment platform.

In March 2022, the company acquired physical function assessment startup Kinesis Health Technologies which will operate as a subsidiary of Linus Health. Linus Health plans to refine and offer more holistic and proactive health screening services via the acquisition.

In March 2024, the company acquired Aural Analytics , a software provider that evaluates speech to assess cognitive conditions. The acquisition was carried out for an undisclosed sum. Linus planned to harness Aural's technology to enhance its cognitive assessment tests. The acquired assets would enable Linus to expand its operations into the life sciences industry, allowing its technology to be used in pharmaceutical trials and clinical research.

In July 2024, Linus Health acquired Together Senior Health, a brain health company delivering evidence-based solutions for individuals with cognitive decline, for an undisclosed sum. Through the acquisition, Linus aimed to expand its platform's capabilities, combining objective and subjective cognitive assessments with actionable guidance for providers and patients.